{"id":496,"date":"2026-02-28T10:26:03","date_gmt":"2026-02-28T10:26:03","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/valve-repair-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T10:26:03","modified_gmt":"2026-02-28T10:26:03","slug":"valve-repair-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/valve-repair-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Valve Repair: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Valve Repair Introduction (What it is)<\/h2>\n\n\n\n<p>Valve Repair is a procedure that fixes a person\u2019s own heart valve so it opens and closes more normally.<br\/>\nIt is a cardiovascular intervention (a procedure), not a diagnosis or a medication.<br\/>\nIt is commonly discussed in the context of valve regurgitation (leakage) and, less often, select forms of valve stenosis (narrowing).<br\/>\nIt is encountered in cardiology clinics, echocardiography labs, heart team conferences, and cardiac surgery or structural heart programs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Valve Repair matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Heart valves maintain one-way blood flow through the heart. When a valve fails to close tightly (regurgitation) or fails to open fully (stenosis), the heart must work harder to maintain forward flow. Over time, this can contribute to symptoms such as shortness of breath and fatigue, and it can lead to cardiac chamber dilation, atrial fibrillation (AF), pulmonary hypertension, heart failure, and reduced exercise capacity.<\/p>\n\n\n\n<p>Valve Repair matters because it aims to restore valve function while preserving the patient\u2019s native valve tissue and supporting structures. In many clinical pathways, deciding between Valve Repair and valve replacement affects long-term planning, including follow-up imaging, antithrombotic therapy considerations, and the likelihood of future interventions. From an educational perspective, Valve Repair is a practical \u201cbridge topic\u201d connecting anatomy (leaflets, chordae, annulus), physiology (pressure and volume loading), imaging interpretation (echocardiography), and clinical decision-making (timing of intervention, procedural approach, and risk assessment).<\/p>\n\n\n\n<p>In modern cardiology, Valve Repair also reflects team-based care. Decisions often involve a multidisciplinary \u201cheart team\u201d approach (cardiologists, cardiac surgeons, imaging specialists, anesthesiologists, and others), especially when transcatheter and surgical options are both possible. Specific recommendations vary by clinician and case, and by protocol and patient factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Valve Repair can be categorized in several clinically useful ways:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By valve involved<\/strong><\/li>\n<li><strong>Mitral Valve Repair<\/strong> (commonly for mitral regurgitation)<\/li>\n<li><strong>Tricuspid Valve Repair<\/strong> (often for tricuspid regurgitation, including functional\/secondary disease)<\/li>\n<li><strong>Aortic Valve Repair<\/strong> (selected patients, including certain bicuspid aortic valve phenotypes or valve-sparing root operations)<\/li>\n<li>\n<p><strong>Pulmonic Valve Repair<\/strong> (less common; may be relevant in congenital heart disease)<\/p>\n<\/li>\n<li>\n<p><strong>By approach<\/strong><\/p>\n<\/li>\n<li><strong>Surgical Valve Repair<\/strong><ul>\n<li>Conventional open surgery (sternotomy) or minimally invasive surgical approaches (varies by center and patient factors)<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Transcatheter (Percutaneous) Valve Repair<\/strong><\/p>\n<ul>\n<li>Commonly described for the mitral valve (e.g., edge-to-edge repair) and increasingly for selected tricuspid anatomies in specialized programs  <\/li>\n<li>Not all valves or mechanisms are amenable to transcatheter repair<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>By mechanism targeted<\/strong><\/p>\n<\/li>\n<li><strong>Annular remodeling<\/strong> (reducing or reshaping a dilated annulus)<\/li>\n<li><strong>Leaflet repair<\/strong> (resection, augmentation, or edge-to-edge techniques to improve coaptation)<\/li>\n<li><strong>Subvalvular repair<\/strong> (chordae tendineae repair\/replacement, papillary muscle-related strategies)<\/li>\n<li>\n<p><strong>Commissural or cusp repair<\/strong> (more typical in some aortic repairs)<\/p>\n<\/li>\n<li>\n<p><strong>By underlying etiology<\/strong><\/p>\n<\/li>\n<li><strong>Primary (degenerative) regurgitation<\/strong>: intrinsic leaflet\/chordal abnormality<\/li>\n<li><strong>Secondary (functional) regurgitation<\/strong>: valve is structurally \u201cnormal,\u201d but the ventricle or atrium is remodeled, tethering leaflets or dilating the annulus<\/li>\n<\/ul>\n\n\n\n<p>These categories are often combined in real cases (for example, mitral Valve Repair with annuloplasty plus chordal replacement for degenerative prolapse).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Four valves coordinate blood flow:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mitral valve<\/strong>: between left atrium (LA) and left ventricle (LV); supported by the annulus, anterior and posterior leaflets, chordae tendineae, and papillary muscles.<\/li>\n<li><strong>Aortic valve<\/strong>: between LV and aorta; typically three cusps (or two in bicuspid aortic valve), with sinuses and commissures contributing to opening\/closure mechanics.<\/li>\n<li><strong>Tricuspid valve<\/strong>: between right atrium (RA) and right ventricle (RV); has an annulus and leaflet apparatus similar in concept to the mitral valve.<\/li>\n<li><strong>Pulmonic valve<\/strong>: between RV and pulmonary artery.<\/li>\n<\/ul>\n\n\n\n<p>Key physiologic principles that inform Valve Repair:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Coaptation<\/strong>: the leaflets must meet (coapt) over an adequate surface area during closure to prevent regurgitation.<\/li>\n<li><strong>Annular size and shape<\/strong>: annular dilation can prevent leaflet coaptation even if leaflets are intact.<\/li>\n<li><strong>Ventricular-atrial interaction<\/strong>: LV or RV dilation and altered geometry can tether leaflets, producing secondary regurgitation.<\/li>\n<li><strong>Pressure and volume load<\/strong>:<\/li>\n<li>Regurgitation produces <strong>volume overload<\/strong>, promoting chamber dilation and eccentric remodeling.<\/li>\n<li>Stenosis produces <strong>pressure overload<\/strong>, promoting concentric remodeling and higher transvalvular gradients.<\/li>\n<\/ul>\n\n\n\n<p>The conduction system is also relevant because procedures near valve annuli (especially aortic and tricuspid regions) can affect atrioventricular conduction, sometimes requiring pacing support depending on anatomy and procedural factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>Valve Repair is designed to correct the mechanical problem causing valve dysfunction, most commonly regurgitation. The mechanism depends on the valve and the underlying lesion:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Mitral regurgitation (MR)<\/strong><\/li>\n<li><strong>Primary MR (degenerative)<\/strong>: leaflet prolapse or flail from chordal elongation\/rupture; repair strategies may include chordal replacement, leaflet reshaping, and annuloplasty to restore coaptation.<\/li>\n<li>\n<p><strong>Secondary MR (functional)<\/strong>: LV dilation or papillary muscle displacement tethers leaflets; repair often focuses on annular reduction and improving leaflet apposition, though durability can vary by patient factors and ventricular remodeling.<\/p>\n<\/li>\n<li>\n<p><strong>Tricuspid regurgitation (TR)<\/strong><\/p>\n<\/li>\n<li>\n<p>Frequently functional, related to RV dilation, pulmonary hypertension, or longstanding AF with annular enlargement. Repair often emphasizes annuloplasty and leaflet coaptation strategies.<\/p>\n<\/li>\n<li>\n<p><strong>Aortic valve dysfunction<\/strong><\/p>\n<\/li>\n<li>\n<p>Aortic regurgitation can result from cusp prolapse, cusp restriction, or aortic root dilation. Some repairs address the cusps directly, while others address the supporting root\/annulus (e.g., valve-sparing root approaches in selected contexts). Suitability is anatomy-dependent and varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>How repair produces clinical effect<\/strong><\/p>\n<\/li>\n<li><strong>Reduces regurgitant volume<\/strong> by improving leaflet coaptation and stabilizing the annulus.<\/li>\n<li><strong>Improves forward stroke volume efficiency<\/strong>, often lowering atrial pressures and pulmonary venous congestion.<\/li>\n<li><strong>Limits maladaptive remodeling<\/strong> when performed at an appropriate time in the disease course (timing is individualized and protocol-dependent).<\/li>\n<\/ul>\n\n\n\n<p>Transcatheter Valve Repair technologies achieve similar functional goals\u2014typically by changing leaflet geometry (e.g., bringing leaflets together) or reshaping the annulus\u2014without open surgery. The exact mechanism and candidacy criteria depend on device design and patient anatomy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Valve Repair is commonly considered in scenarios such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptomatic severe valve regurgitation<\/strong> (e.g., exertional dyspnea, reduced exercise tolerance, fatigue) with supportive imaging findings.<\/li>\n<li><strong>Asymptomatic but significant regurgitation<\/strong> when there is concern for evolving chamber enlargement, declining ventricular function, rising pulmonary pressures, or new atrial arrhythmias (thresholds vary by guideline, clinician, and patient factors).<\/li>\n<li><strong>Degenerative mitral valve prolapse<\/strong> with severe MR where repair feasibility appears high on imaging and surgical assessment.<\/li>\n<li><strong>Secondary (functional) MR<\/strong> in selected patients despite guideline-directed medical therapy for heart failure, often evaluated by a heart team (selection varies by protocol and patient factors).<\/li>\n<li><strong>Functional TR<\/strong> associated with annular dilation (sometimes during left-sided valve surgery or as a standalone intervention in selected patients).<\/li>\n<li><strong>Infective endocarditis<\/strong> with valve destruction or severe regurgitation where repair may be feasible after multidisciplinary assessment (feasibility depends on extent and location of infection).<\/li>\n<li><strong>Congenital or structural lesions<\/strong> (more often in specialized congenital programs) where preserving native valve tissue is desirable.<\/li>\n<\/ul>\n\n\n\n<p>Indications are individualized. The decision to pursue Valve Repair typically integrates symptoms, imaging severity, ventricular size and function, comorbidities, operative\/procedural risk, and patient goals.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Evaluation for Valve Repair generally proceeds from clinical assessment to targeted imaging, with additional testing for procedural planning:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and physical examination<\/strong><\/li>\n<li>Symptoms: exertional dyspnea, orthopnea, fatigue, reduced exercise tolerance, edema (more common with right-sided disease).<\/li>\n<li>\n<p>Examination: murmurs, signs of congestion, irregular rhythm (suggesting AF), and evidence of right-sided volume overload in TR.<\/p>\n<\/li>\n<li>\n<p><strong>Electrocardiogram (ECG)<\/strong><\/p>\n<\/li>\n<li>\n<p>Looks for AF, conduction abnormalities, prior infarction patterns, and baseline intervals relevant to procedural planning.<\/p>\n<\/li>\n<li>\n<p><strong>Transthoracic echocardiography (TTE)<\/strong><\/p>\n<\/li>\n<li>First-line imaging for valve anatomy and function.<\/li>\n<li>\n<p>Interprets regurgitation mechanism (degenerative vs functional), chamber size\/function, pulmonary pressures (estimated), and associated lesions.<\/p>\n<\/li>\n<li>\n<p><strong>Transesophageal echocardiography (TEE)<\/strong><\/p>\n<\/li>\n<li>Adds higher-resolution anatomy, commonly used when TTE is limited or when procedural planning requires detailed leaflet and subvalvular assessment.<\/li>\n<li>\n<p>Often used intraprocedurally for transcatheter repairs and many surgical cases.<\/p>\n<\/li>\n<li>\n<p><strong>Cardiac computed tomography (CT)<\/strong><\/p>\n<\/li>\n<li>\n<p>Used in selected cases to define annular dimensions, calcification, vascular access, aortic root anatomy, and relationships to coronary arteries (use varies by valve and program).<\/p>\n<\/li>\n<li>\n<p><strong>Cardiac magnetic resonance (CMR)<\/strong><\/p>\n<\/li>\n<li>\n<p>Can help quantify regurgitant volume and ventricular remodeling when echocardiographic assessment is uncertain or discordant.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary evaluation<\/strong><\/p>\n<\/li>\n<li>Many candidates (especially older patients or those with risk factors) undergo coronary assessment before intervention; the method (CT coronary angiography vs invasive angiography) varies by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<p>Interpretation centers on matching <strong>mechanism<\/strong> (what is wrong anatomically) to <strong>severity<\/strong> (how much it affects flow and chamber pressures) and <strong>feasibility<\/strong> (whether repair is technically realistic with acceptable residual dysfunction).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management of valvular disease often includes a spectrum from observation to intervention. Valve Repair fits into this broader pathway:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Conservative and medical management<\/strong><\/li>\n<li>For mild disease or stable patients, clinicians may monitor with periodic clinical visits and echocardiography.<\/li>\n<li>\n<p>Medical therapy can treat consequences (e.g., heart failure symptoms, hypertension, AF rate\/rhythm strategies) and may reduce functional regurgitation in some patients. Medications do not directly \u201cfix\u201d a structurally abnormal leaflet.<\/p>\n<\/li>\n<li>\n<p><strong>Interventional\/surgical management<\/strong><\/p>\n<\/li>\n<li><strong>Valve Repair<\/strong> is pursued when restoring native valve function is feasible and aligns with patient-specific risk\/benefit considerations.<\/li>\n<li>\n<p><strong>Valve replacement<\/strong> (surgical or transcatheter) is considered when repair is not feasible, not expected to be durable, or when stenosis\/calcification is dominant.<\/p>\n<\/li>\n<li>\n<p><strong>Surgical Valve Repair (examples of techniques)<\/strong><\/p>\n<\/li>\n<li><strong>Annuloplasty<\/strong>: implantation of a ring or band to reduce and stabilize the annulus (common in mitral and tricuspid repair).<\/li>\n<li><strong>Chordal repair\/replacement<\/strong>: use of artificial chordae or chordal transfer to correct prolapse.<\/li>\n<li><strong>Leaflet repair<\/strong>: resection or remodeling for redundant leaflet tissue; patch augmentation in selected settings.<\/li>\n<li>\n<p><strong>Valve-sparing aortic root procedures<\/strong> (selected patients): address root dilation while preserving valve cusps when appropriate.<\/p>\n<\/li>\n<li>\n<p><strong>Transcatheter Valve Repair (examples of concepts)<\/strong><\/p>\n<\/li>\n<li><strong>Edge-to-edge repair<\/strong>: approximates leaflets to reduce regurgitation (commonly discussed for mitral; evolving for tricuspid in selected programs).<\/li>\n<li><strong>Transcatheter annuloplasty<\/strong>: reduces annular dimension via device-based remodeling (availability and candidacy vary).<\/li>\n<li>Patient selection depends on anatomy, severity, comorbidities, and local expertise.<\/li>\n<\/ul>\n\n\n\n<p>Across approaches, shared principles include careful pre-procedural imaging, assessment of frailty and comorbid conditions, planning for anticoagulation\/antiplatelet strategies when relevant, and structured follow-up. Specific treatment choices vary by clinician and case, and by protocol and patient factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Complications and limitations depend on the valve, approach (surgical vs transcatheter), and patient factors. Commonly discussed categories include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Residual or recurrent regurgitation<\/strong><\/li>\n<li>\n<p>May occur if coaptation remains inadequate or if ventricular\/annular remodeling progresses (particularly relevant in functional regurgitation).<\/p>\n<\/li>\n<li>\n<p><strong>Iatrogenic stenosis<\/strong><\/p>\n<\/li>\n<li>\n<p>Overcorrection or restricted leaflet motion can narrow the effective orifice area, depending on technique and anatomy.<\/p>\n<\/li>\n<li>\n<p><strong>Bleeding and transfusion risk<\/strong><\/p>\n<\/li>\n<li>\n<p>Higher with open procedures; also influenced by antithrombotic therapy and patient comorbidities.<\/p>\n<\/li>\n<li>\n<p><strong>Stroke or systemic embolism<\/strong><\/p>\n<\/li>\n<li>\n<p>Risk varies by procedure type, rhythm (e.g., AF), and peri-procedural management.<\/p>\n<\/li>\n<li>\n<p><strong>Infection<\/strong><\/p>\n<\/li>\n<li>\n<p>Includes wound infection (surgical) and infective endocarditis (any valve intervention carries some risk).<\/p>\n<\/li>\n<li>\n<p><strong>Arrhythmias and conduction disturbances<\/strong><\/p>\n<\/li>\n<li>AF can be present pre-procedure or occur postoperatively.<\/li>\n<li>\n<p>Conduction block and need for pacemaker can occur, particularly with interventions near conduction tissue (risk is context-dependent).<\/p>\n<\/li>\n<li>\n<p><strong>Vascular complications (transcatheter procedures)<\/strong><\/p>\n<\/li>\n<li>\n<p>Access-site bleeding, hematoma, pseudoaneurysm, or vessel injury.<\/p>\n<\/li>\n<li>\n<p><strong>Anatomic limitations<\/strong><\/p>\n<\/li>\n<li>Severe calcification, unfavorable leaflet geometry, advanced tethering, or extensive tissue destruction (e.g., endocarditis) can limit repair feasibility.<\/li>\n<\/ul>\n\n\n\n<p>These risks are typically discussed in informed consent, with estimates tailored to the patient and local outcomes where available.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis after Valve Repair is influenced by the underlying valve disease, the timing of intervention relative to ventricular remodeling, and coexisting conditions (e.g., coronary artery disease, pulmonary hypertension, AF, chronic kidney disease). Functional regurgitation related to ventricular disease may have different long-term dynamics than primary degenerative disease, because the ventricle can continue to remodel even after the valve is mechanically improved.<\/p>\n\n\n\n<p>Follow-up commonly involves:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical assessment<\/strong><\/li>\n<li>\n<p>Symptom tracking, functional capacity, volume status, and rhythm evaluation.<\/p>\n<\/li>\n<li>\n<p><strong>Echocardiographic surveillance<\/strong><\/p>\n<\/li>\n<li>\n<p>Used to assess residual regurgitation\/stenosis, ventricular size and function, and pulmonary pressures over time. Frequency varies by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Rhythm and anticoagulation considerations<\/strong><\/p>\n<\/li>\n<li>\n<p>AF management and antithrombotic strategies may be relevant depending on rhythm, comorbidities, and the type of intervention. Plans are individualized.<\/p>\n<\/li>\n<li>\n<p><strong>Rehabilitation and return to activity<\/strong><\/p>\n<\/li>\n<li>Recovery trajectories vary widely by procedure type (open vs minimally invasive vs transcatheter), baseline fitness, and complications. Many programs use structured cardiac rehabilitation pathways when appropriate.<\/li>\n<\/ul>\n\n\n\n<p>Long-term outcomes depend on procedural success (durable reduction in regurgitation without creating stenosis), ventricular recovery or stabilization, and management of contributing conditions such as hypertension, ischemia, and heart failure.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Valve Repair Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Valve Repair mean in plain language?<\/strong><br\/>\nValve Repair means fixing a heart valve so it closes and opens more effectively, usually by reshaping or supporting the valve rather than replacing it. The goal is to improve one-way blood flow and reduce leakage. It is a procedure, not a medication.<\/p>\n\n\n\n<p><strong>Q: Is Valve Repair the same as valve replacement?<\/strong><br\/>\nNo. Valve Repair preserves the patient\u2019s native valve tissue and supporting structures when feasible. Valve replacement removes or bypasses the native valve function with a prosthetic valve, and follow-up considerations can differ.<\/p>\n\n\n\n<p><strong>Q: Which valves can be repaired?<\/strong><br\/>\nMitral and tricuspid valves are commonly repaired, especially for regurgitation. Aortic valve repair is performed in selected patients depending on cusp and root anatomy. Suitability varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: How do clinicians decide if repair is possible?<\/strong><br\/>\nDecision-making relies heavily on echocardiography to define the mechanism of dysfunction (leaflet prolapse, tethering, annular dilation, calcification). Clinicians also consider overall health, surgical or procedural risk, and whether a durable result is likely. Many centers use a multidisciplinary heart team model.<\/p>\n\n\n\n<p><strong>Q: What tests are usually done before Valve Repair?<\/strong><br\/>\nMost patients have a transthoracic echocardiogram, and many undergo transesophageal echocardiography for more detail. Additional testing may include ECG, laboratory evaluation, coronary assessment, and sometimes cardiac CT or CMR for procedural planning. The exact workup varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Is Valve Repair considered \u201cmajor surgery\u201d?<\/strong><br\/>\nSurgical Valve Repair is typically a major operation, although minimally invasive techniques may reduce incision size and recovery time for some patients. Transcatheter Valve Repair is less invasive than open surgery but is still a significant cardiovascular procedure with specific risks and follow-up needs.<\/p>\n\n\n\n<p><strong>Q: What is recovery like after Valve Repair?<\/strong><br\/>\nRecovery depends on the approach (open surgical vs minimally invasive vs transcatheter), baseline function, and complications. Many patients experience gradual improvement in symptoms as congestion improves and conditioning returns. Timelines vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Will I need medications after Valve Repair?<\/strong><br\/>\nSome patients need medications after repair, such as therapies for heart failure, blood pressure control, or atrial fibrillation management. Antithrombotic plans may be recommended depending on rhythm and the type of repair. Specific regimens vary by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: How is success assessed after Valve Repair?<\/strong><br\/>\nClinicians assess symptom change, physical findings, and post-procedure imaging\u2014most commonly echocardiography\u2014to evaluate residual regurgitation or stenosis and ventricular response. They also monitor for complications such as arrhythmias. Long-term success includes durability over time.<\/p>\n\n\n\n<p><strong>Q: Can valve problems come back after a repair?<\/strong><br\/>\nRecurrence can happen, particularly if the underlying driver (like ventricular dilation or pulmonary hypertension) progresses. Degenerative disease can also evolve in remaining tissue. Follow-up imaging helps detect changes early, and next steps depend on the mechanism and severity of recurrence.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Valve Repair is a procedure that fixes a person\u2019s own heart valve so it opens and closes more normally. It is a cardiovascular intervention (a procedure), not a diagnosis or a medication. It is commonly discussed in the context of valve regurgitation (leakage) and, less often, select forms of valve stenosis (narrowing). It is encountered in cardiology clinics, echocardiography labs, heart team conferences, and cardiac surgery or structural heart programs.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-496","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=496"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/496\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}